As of August 28, 2026, Xenetic Biosciences, Inc. (XBIO) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Xenetic Biosciences, Inc. has a market capitalization of $7.22M, 2.34M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for XBIO.
Market Data
Market Cap$7.22M
Shares Outstanding2.34M
Float1.78M
Cash$6.47M
Debt$585.6K
Short InterestN/A
Institutional Holdings
7.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest11.3K
Days to Cover1.0
% of Float0.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2016-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual XBIO Dilution Snapshot
Xenetic Biosciences, Inc. (XBIO) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for XBIO: xbrl on 2026-06-30; xbrl on 2016-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track XBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XBIO — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for XBIO
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.